Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETF · Direct ✕Nippon India Nifty Pharma ETF · Direct ✕

Growth of ₹10,000

Basics

ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETFNippon India Nifty Pharma ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseAngel OneNippon India
AUM₹15 Cr₹1,700 Cr
NAV₹10.0195₹29.1863
NAV date20 Nov 202620 Nov 2026
History12 months5.4 years
Expense ratio0.8%0.2%
StarsNot ratedNot rated
Growth Score——

AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.

Returns

ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETFNippon India Nifty Pharma ETF
1 month+2.96%+10.82%
3 months−2.98%+7.43%
6 months−1.96%+14.54%
YTD+4.10%+25.40%
1 year+0.15%+25.57%
3 years (CAGR)—+22.02%
5 years (CAGR)—+16.60%
10 years (CAGR)——
Since launch+0.15%+14.02%

Risk

ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETFNippon India Nifty Pharma ETF
Volatility—15.0%
Downside volatility—9.0%
Sharpe—1.04
Sortino—1.72
Calmar—1.33
Return / risk—1.47
Deepest fall−12.72%−20.98%
Days to recover25136
Below its high−4.72%−1.75%

Against benchmark

ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETFNippon India Nifty Pharma ETF
Alpha—−0.23%
Beta—1.00
R²—100.0%
Up capture—99.6%
Down capture—100.6%
Tracking error—0.0%
Information ratio—−42.00
Treynor—0.14

Consistency

ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETFNippon India Nifty Pharma ETF
Best 1-year—+65.21%
Middle 1-year—+13.46%
Worst 1-year—−15.30%
1-year periods with a loss—25.8%
Middle 3-year—+20.51%
Positive months—61.1%
Best day+4.18%+3.64%
Worst day−3.73%−4.03%
Worst 5% day−2.11%−1.62%
Positive days51.7%54.4%
NAVs a year243248

SIP of ₹10,000 a month

ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETFNippon India Nifty Pharma ETF
5-year XIRR—+20.60%
5-year value—₹10,11,738
3-year XIRR—+19.58%
1-year XIRR—+34.31%

Holdings overlap i

ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETFNippon India Nifty Pharma ETF
ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETF
Direct · filing Oct 2026
—6%
Nippon India Nifty Pharma ETF
Direct · filing Oct 2026
6%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETF and Nippon India Nifty Pharma ETF

Overlap
6.0%
smaller weight of each shared stock, added up
Stocks in common
2
of 50 and 20
Weight in common
6% · 8%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
Common stockANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETFNippon India Nifty Pharma ETFCounts toward overlap
Torrent Pharmaceuticals Limited4.89%6.71%4.89%
Ajanta Pharma Limited1.08%1.58%1.08%
2 stocks6.0%8.3%6.0%

Only in ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETF (48)

Multi Commodity Exchange of India Limited5.57%
Bajaj Auto Limited5.36%
Eicher Motors Limited5.22%
BSE Limited4.88%
Coal India Limited4.76%
Bharat Electronics Limited4.75%
Ge Vernova T&D India Limited4.60%
CG Power and Industrial Solutions Limited4.56%
Cummins India Limited4.27%
Cupid Limited4.08%
Solar Industries India Limited3.50%
Polycab India Limited3.28%
Marico Limited3.08%
Hitachi Energy India Limited3.02%
HDFC Asset Management Company Limited2.60%
Acutaas Chemicals Limited2.52%
Apar Industries Limited2.36%
Bosch Limited2.36%
ABB India Limited2.35%
Anand Rathi Wealth Limited2.15%
National Aluminium Co Limited2.03%
Oracle Financial Services Software Limited1.78%
TD Power Systems Limited1.60%
KEI Industries Limited1.54%
Bank Of Maharashtra1.37%

and 23 smaller holdings (10.4% of the fund).

Only in Nippon India Nifty Pharma ETF (18)

Sun Pharmaceutical Industries Limited18.61%
Divi's Laboratories Limited12.28%
Laurus Labs Limited9.26%
Dr. Reddy's Laboratories Limited8.15%
Cipla Limited7.67%
Lupin Limited4.83%
Aurobindo Pharma Limited4.59%
Glenmark Pharmaceuticals Limited3.42%
Zydus Lifesciences Limited3.05%
Alkem Laboratories Limited3.05%
Mankind Pharma Limited2.79%
IPCA Laboratories Limited2.65%
Gland Pharma Limited2.44%
Biocon Limited2.42%
Sai Life Sciences Limited2.13%
Wockhardt Limited1.55%
Piramal Pharma Limited1.47%
Abbott India Limited1.32%

Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.

Sectors and company size

ANGEL ONE NIFTY TOTAL MARKET MOMENTUM QUALITY 50 ETFNippon India Nifty Pharma ETF
Large companies53.4%45.3%
Mid companies29.0%47.1%
Small companies15.9%7.6%
Top 10 holdings48.9%78.6%
Largest sectorElectrical Equipment 19%Pharmaceuticals & Biotechnology 100%

Search Growth